Harbor Capital Advisors, Inc. Akouos, Inc. Transaction History

Harbor Capital Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$2.6 - $5.16 $9,370 - $18,596	3,604 Added 4.46%	84,358 $570,000
Q2 2022 Jul 26, 2022	BUY	$2.46 - $5.2 $7,229 - $15,282	2,939 Added 3.78%	80,754 $379,000
Q1 2022 Apr 28, 2022	SELL	$4.16 - $9.08 $60,565 - $132,195	-14,559 Reduced 15.76%	77,815 $370,000
Q4 2021 Feb 04, 2022	BUY	$7.65 - $11.38 $706,661 - $1.05 Million	92,374 New	92,374 $785,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.